Target intelligence / Profile preview

Human immunodeficiency virus type 1 Negative Regulatory Factor – Src-family kinase Src homology 3 interface (Nef-SH3 interface)

Target
Nef-SH3 interface
Molecular classification
Protein-protein interaction, Viral accessory protein, Non-receptor tyrosine kinase
01

Overview

HIV-1 Nef is a multifunctional accessory protein that is essential for the high-titer replication of the human immunodeficiency virus and the progression to AIDS [1, 4]. Lacking enzymatic activity, Nef functions as a molecular adaptor that hijacks host cell signaling and trafficking machinery through various protein-protein interactions [1, 6]. A key interaction involves the binding of the conserved PxxPxR motif in Nef to the Src homology 3 (SH3) domains of host Src-family kinases (SFKs), such as Hck, Lyn, and c-Src [3, 9]. This interaction displaces the SH3 domain from its auto-inhibitory position, leading to the constitutive activation of the kinase [7, 8]. This signaling event is critical for enhancing viral infectivity and promoting immune evasion by facilitating the downregulation of major histocompatibility complex class I (MHC-I) from the surface of infected cells [6, 11, 15]. Small-molecule inhibitors targeting the Nef-SH3 interface are being developed to disrupt these processes, thereby suppressing viral replication and restoring the immune system's ability to recognize and eliminate HIV-infected cells [10, 11, 14]. These inhibitors offer a novel therapeutic approach that could complement existing antiretroviral therapies by targeting viral persistence and immune escape mechanisms [6, 11]. Preclinical studies have identified several chemical scaffolds, including hydroxypyrazoles and isothiazolones, that effectively block this interaction and its downstream effects [10, 11]. The development of these agents faces challenges such as ensuring specificity to avoid interfering with normal host kinase functions and addressing the high mutation rate of the HIV-1 genome [2, 6]. Overall, the Nef-SH3 interface represents a high-value target for the next generation of HIV treatments aimed at achieving a functional cure [1, 14].

Other names
Nef-Hck interactionNef-SFK interactionNef-SH3 domain interactionNef-PxxPxR motif interactionHIV-1 Nef-Src homology 3 domain complex
02

Mechanism of action

Inhibition of the protein-protein interaction between HIV-1 Nef and host Src-family kinase SH3 domains, preventing allosteric kinase activation and restoring MHC-I surface expression.

03

Biological functions

Viral replicationImmune evasionSignal transductionEndosomal traffickingT-cell activation
04

Disease associations

Infection
05

Safety considerations

Off-target inhibition of host Src-family kinasesEmergence of drug-resistant viral mutationsPotential for systemic toxicity due to interference with host signaling pathways
06

Interacting drugs

D1

4 more in the full profile.

07

Biomarkers

HIV-1 viral loadCD4+ T-cell countMHC-I surface expression

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 Negative Regulatory Factor – Src-family kinase Src homology 3 interface (Nef-SH3 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 Negative Regulatory Factor – Src-family kinase Src homology 3 interface (Nef-SH3 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call